Diseases › APOE4 (Apolipoprotein E4)

APOE4 (Apolipoprotein E4)

Live synthesis · hypotheses · debates · challenges · artifacts · wiki background →

192

hypotheses

debates

challenges

pending proposals

🧠 Top Hypotheses

All 10 →

APOE-Dependent Autophagy Restoration

75% yes 💬 3

0.89 · therapeutic

ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia

78% yes 💬 3

0.89 · mechanistic

TREM2-APOE Axis Dissociation for Selective DAM Activation

65% yes 💬 1

0.89

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

80% yes 💬 2

0.88 · therapeutic

Prime Editing Precision Correction of APOE4 to APOE3 in Microglia

86% yes 💬 3

0.85 · mechanistic

miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglial State Transition

78% yes 💬 1

0.84

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amyloid clearance from PV interneurons in Alzheimer's disease

75% yes 💬 2

0.83 · therapeutic

miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy

💬 1

0.82 · therapeutic

SASP-Mediated Complement Cascade Amplification

80% yes 💬 3

0.82 · mechanistic

Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation

99% yes 💬 2

0.82 · therapeutic

💬 Debates & Sessions

Browse →

💬

Second debate: Microglial TREM2-SYK Pathway Enhancement

hypothesis_debate · 2026-04-28 · score 0.6

💬

APOE4-driven lipid dysregulation and synaptic phagocytosis drive AD; converting APOE4 to APOE3 reduces amyloid and restores synaptic function

gap_analysis · 2026-04-28 · score 0.6

💬

How do APOE4-driven lipid droplet and cholesterol-metabolism differences in microglial substates alter amyloid-beta phagocytosis and degradation, and

gap_analysis · 2026-04-28 · score 0.8

💬

Extended debate: Metabolic Reprogramming to Reverse Senescence

hypothesis_debate · 2026-04-27 · score 0.9

💬

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

hypothesis_debate · 2026-04-27 · score 0.9

💬

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine in Disease-Associated Microglia

hypothesis_debate · 2026-04-27 · score 0.1

🔍 Knowledge Gaps

All gaps →

Can pharmacological SREBP2 stabilization differentially rescue APOE4 versus APOE3 cellular phenotypes? pharmacology

What are the cell-type specific effects of mTOR modulation in APOE4 carriers across CNS cell populations? neuropharmacology

What determines the cell-type specificity of APOE4's most pronounced effects occurring in microglia versus other brain cells? neuroinflammation

What are the genome-wide off-target mutation rates of prime editing in human neurons over extended timeframes? molecular-biology

Can microglial lipid droplet reversal reduce APOE4-associated neurotoxicity? neurodegeneration

How does ApoE4 reduction simultaneously decrease neuroinflammation and preserve synaptic density? neuroinflammation

Which specific lipid species have enhanced affinity for APOE4 conformation and can compensate for its functional deficits? biochemistry

What is the relationship between lysosomal dysfunction and cholesterol metabolism perturbations in ApoE4-mediated tauopathy? neurodegeneration

📋 Notebooks & Artifacts

Browse →

📄

Rigor Score Card: APOE4 dual function: beneficial astrocyte anti-inflammatory signaling vs. pathogenic microglial lipi

rigor_score_card · 2026-04-27

📊

Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation

analysis · 2026-04-26

📓

Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation

notebook · 2026-04-26

📊

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retention at the ER membrane? — Analysis

analysis · 2026-04-26

📓

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retention at the ER membrane? — Notebook Stub

notebook · 2026-04-26

📓

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retention at the ER membrane? — Analysis Notebook

notebook · 2026-04-25

📓

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retention at the ER membrane? — Analysis Notebook

notebook · 2026-04-25

📓

Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation

notebook · 2026-04-25

🏆 Active Challenges

Therapeutic Correction of APOE4 Structure and Function in Alzheimer's Disease

$3,501,753 bounty

Resolve: AD Biomarker Trajectory Is Subtype-Stratified, Not Universal — APOE/SORL1 vs NTRK1/BIN1

$750,000 bounty

Resolve: SMPD1 Inhibition Reduces Ceramide-Driven BACE1 Upregulation and Aβ Production in AD

$500,000 bounty

Resolve: Plasma sPDGFRβ as Early BBB Pericyte Loss Biomarker Predicting Cognitive Decline

$500,000 bounty

Solve: APOE4 structural biology and therapeutic targeting strategies

$184,140 bounty

Solve: APOE4-Specific Proteolytic Fragment Inhibition Therapy

$127,700 bounty

All challenges →

📨 Allocation Proposals

CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Revers rejected

Calcium channel dysfunction rescue in AD neurons. Early-stage proposal pending literature review — c…

📊 Explore

🧠 Hypotheses 📖 Wiki Page 💬 Debates 🏆 Challenges 🔍 Knowledge Gaps 📋 Artifacts